Tardive Dyskinesia Treatment | AUSTEDO XR® (deutetrabenazine)
The most common side effects of AUSTEDO in people with tardive dyskinesia include inflammation of the nose and throat (nasopharyngitis) and problems sleeping (insomnia). …
Tardive Dyskinesia (TD) | AUSTEDO XR® (deutetrabenazine) …
AUSTEDO XR ® (deutetrabenazine) extended-release tablets and AUSTEDO ® (deutetrabenazine) tablets are indicated in adults for the treatment of chorea associated with …
Austedo (deutetrabenazine): Uses, Side Effects, Dosage Guide
Aug 20, 2025 · Austedo is used to treat the involuntary movements of Huntington's disease and tardive dyskinesia (TD). Includes Austedo side effects, dosage, uses, interactions, and more
Real-world data shows AUSTEDO improves life for patients with tardive …
Nov 11, 2025 · Teva Pharmaceuticals has announced new real-world data showing that AUSTEDO (deutetrabenazine) tablets and AUSTEDO XR (extended-release) tablets led to …
AUSTEDO® (deutetrabenazine) tablets and AUSTEDO XR® …
Nov 7, 2025 · AUSTEDO XR and AUSTEDO are the first vesicular monoamine transporter 2 (VMAT2) inhibitors approved by the U.S. Food and Drug Administration in adults for the …
Teva Real-World Study Finds AUSTEDO and AUSTEDO XR …
Nov 11, 2025 · The findings demonstrate that treatment with AUSTEDO (deutetrabenazine) tablets or AUSTEDO XR (deutetrabenazine) extended-release tablets for tardive dyskinesia …
Teva Pharmaceuticals Reports Positive Real-World Data on AUSTEDO …
Nov 7, 2025 · Teva Pharmaceuticals presented new findings from the IMPACT-TD Registry indicating that treatment with AUSTEDO and AUSTEDO XR significantly improved the lives of …
AUSTEDO XR® Medication for Tardive Dyskinesia (TD)
The most common side effects of AUSTEDO in people with tardive dyskinesia include inflammation of the nose and throat (nasopharyngitis) and problems sleeping (insomnia). The …
Treatment Strategies for Tardive Dyskinesia - U.S. Pharmacist
Nov 14, 2025 · Tardive dyskinesia (TD) is a potentially permanent neurologic disorder that is characterized by abnormal, involuntary, and repetitive movements, often impacting the face, …
Austedo XR Approved: A New Treatment Option for Tardive Dyskinesia …
May 30, 2024 · The US Food and Drug Administration (FDA) has approved Teva Pharmaceuticals’ Austedo XR (deutetrabenazine) as a once-daily pill treatment option, …